Update on ocular cicatricial pemphigoid and emerging treatments.

Surv Ophthalmol

Massachusetts Eye Research and Surgery Institution, Waltham, Massachusetts, USA; Ocular Immunology and Uveitis Foundation, Waltham, Massachusetts, USA; Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, USA. Electronic address:

Published: September 2016

Mucous membrane pemphigoid is a systemic disorder that primarily affects mucous membranes. When localized to the conjunctiva, it is known as ocular cicatricial pemphigoid, a potentially blinding disease. Ocular cicatricial pemphigoid is an indication for systemic immunosuppressive treatment to achieve adequate remission. Immunosuppressive agents are selected with a "stepladder" approach, commencing with medications having the fewest side effects. We provide an update of the literature on immunomodulatory agents since 2011 as additional treatment modalities have been explored in the last 4 years.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.survophthal.2015.12.007DOI Listing

Publication Analysis

Top Keywords

ocular cicatricial
12
cicatricial pemphigoid
12
update ocular
4
pemphigoid
4
pemphigoid emerging
4
emerging treatments
4
treatments mucous
4
mucous membrane
4
membrane pemphigoid
4
pemphigoid systemic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!